Načítá se...

Concurrent chemoradiation for high-risk prostate cancer

There are estimated to be 220800 cases of prostate cancer diagnosed in 2015, making up 26% of all cancer diagnoses. Fortunately, adenocarcinoma of the prostate is often a highly treatable malignancy. Even though the majority of prostate cancer patients present with localized disease, prostate cancer...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Clin Oncol
Hlavní autoři: Cooper, Benjamin T, Sanfilippo, Nicholas J
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530376/
https://ncbi.nlm.nih.gov/pubmed/26266099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v6.i4.35
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!